Hospital Medicine News

The Department of Medicine held its inaugural Research Day on Friday, April 28, with Chair Kathleen Cooney, MD, kicking off the event with a special Medicine Grand Rounds presentation about her research, Hereditary Prostate Cancer: From Gene Discovery to Clinical Implementation.  

Shelley R. McDonald, DO, PhD, associate professor in the division of Geriatrics, has been selected as the 2023 American Geriatrics Society Clinician of the Year.

Duke Institute for Health Innovation (DIHI) recently announced their innovation projects to be implemented as part of DIHI’s annual call for project ideas in Automation to Enhance Healthcare Operational Efficiency. Among the recipients were 3 projects that included members from Duke GIM (bolded):

This Administrative Professionals Day, we'd like to recognize our more than 250 administrative professionals in the Department of Medicine!

Earth Day is a time to raise awareness of the need to protect Earth's natural resources for future generations. It’s also time to have cross-discipline conversations about plastic pollution’s impact on human health, says two School of Medicine researchers with Duke University’s Plastic Pollution Working Group (PPWG). 

Dr. William Yancy became the Interim Division Chief of General Internal Medicine (GIM) in January 2023. His leadership embodies the tripartite mission of patient care, research, and education that remains the foundation of the Department of Medicine.

Andrew Muir, MD, MHS, will serve as the next Vice Chair of Clinical Affairs for the Department of Medicine, beginning April 1.  He will continue in his role as the Chief of the Division of Gastroenterology. 

After a decade of debate, North Carolina is poised to expand the state’s Medicaid program.  A cohort of Duke internal medicine residents has been advocating for the expansion for years, playing a small but powerful—perhaps even pivotal—role in moving expansion legislation forward.

R38 scholar Aaditya Khatri, MD, PhD, is the lead author on a new study that offers a potentially novel therapeutic strategy for the prevention or treatment of chronic lung allograft dysfunction (CLAD), the leading cause of death in lung transplant recipients. 

Dana Clifton, MD, and Christopher Prater, MD, MPH, will assume the positions of Associate Program Directors of the combined Internal Medicine-Pediatrics Residency Program, effective July 2023.